Linda Rhein Email & Phone Number | 25 years experience in R&D research functions in skin care in fields of topical medications for both Rx and OTC indications and in cleansers / detergents with pharmaceuticals, cosmetic, personal care, and feminine care companies. Experience in fundamental applied research in dermatology and surfactant science. Have technical and managerial experience with dermatologic clinical development / medical affairs functions. Have managed as many as 16 staff in 3 departments ranging from Ph.D. chemists / biochemists, MDs, pharmacologist, clinicians, product development chemists\engineers, and administrative staff. Have had responsibility for full efficacy and safety programs for securing FDA approval of new sunscreens, including the preparation of clinical, pharmacokinetic and toxicology sections of 4 NDAs for a new chemical entity (sunscreen) now approved and marketed. Have led clinical development of the successful switch of a single dose vaginal candidiasis topical medication, switch of an antidandruff shampoo, clinical Rx and OTC programs for antifungals for cutaneous fungal infections, antiviral clinical trials for cold sores, and treatments for acne, antibacterials, dry skin, stretch marks, eczema, psoriasis and topical analgesics. Have led development of 7 marketed Oxy acne treatment products on a superior mildness platform based on clinical and sensory (perceived) mildness. Have global experience preparing CTD submissions and in global drug safety pharmacovigilance including assessment of cases, signal detection, and preparation of Annual Reports, PSRs, PSURs, Addendum Reports and Summary Bridging Reports for EU Health Authorities and FDA. Specialties: Clinical research dermatologics, drug safety and pharmacovigilance, surfactant science and skin care, regulatory submissions and regulatory affairs, leader in cosmetic field and past (elected) president of Society of Cosmetic Chemists, 50+ publications and editor of 3 books, past adjunct professor Fairleigh Dickinson Masters Program in Cosmetic Science

Linda Rhein

25 years experience in R&D research functions in skin care in fields of topical medications for both...
300 Woods Run Road, Muncy, United States

*50 free lookup(s) per month.

No credit card required.

Linda Rhein’s Email linda.rhein@bayer.com

Linda Rhein’s Phone Numbers

Get LINDA’s Phone Number (For Free)

Social Media

Linda Rhein’s Location 300 Woods Run Road, Muncy, United States

Linda Rhein’s Current Industry Bayer Healthcare

Linda Rhein’s Prior Industry Novartis Consumer | Loreal | Glaxosmithkline | Bristol Myers Products

Not the Linda Rhein you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Bayer Healthcare

Deputy Director, Drug Safety, Global Pharmacovigilance

2007-08-01 00:00:00 - Present

Novartis Consumer

Associate Director, Clinical Research

2006-08-01 00:00:00 - 2007-07-01 00:00:00

Loreal

Director, Drug Approvals Group

2002-08-01 00:00:00 - 2006-08-01 00:00:00

Glaxosmithkline

Director, Dermatology Category

1997-01-01 00:00:00 - 2002-01-01 00:00:00

Bristol Myers Products

Manager

1990-01-01 00:00:00 - 1992-01-01 00:00:00

Skills

No Skills Available

Languages

No Languages Available

FAQ About Linda Rhein

Linda Rhein is located at
300 Woods Run Road, Muncy, United States

Linda Rhein is a 25 years experience in R&D research functions in skin care in fields of topical medications for both Rx and OTC indications and in cleansers / detergents with pharmaceuticals, cosmetic, personal care, and feminine care companies. Experience in fundamental applied research in dermatology and surfactant science. Have technical and managerial experience with dermatologic clinical development / medical affairs functions. Have managed as many as 16 staff in 3 departments ranging from Ph.D. chemists / biochemists, MDs, pharmacologist, clinicians, product development chemists\engineers, and administrative staff. Have had responsibility for full efficacy and safety programs for securing FDA approval of new sunscreens, including the preparation of clinical, pharmacokinetic and toxicology sections of 4 NDAs for a new chemical entity (sunscreen) now approved and marketed. Have led clinical development of the successful switch of a single dose vaginal candidiasis topical medication, switch of an antidandruff shampoo, clinical Rx and OTC programs for antifungals for cutaneous fungal infections, antiviral clinical trials for cold sores, and treatments for acne, antibacterials, dry skin, stretch marks, eczema, psoriasis and topical analgesics. Have led development of 7 marketed Oxy acne treatment products on a superior mildness platform based on clinical and sensory (perceived) mildness. Have global experience preparing CTD submissions and in global drug safety pharmacovigilance including assessment of cases, signal detection, and preparation of Annual Reports, PSRs, PSURs, Addendum Reports and Summary Bridging Reports for EU Health Authorities and FDA. Specialties: Clinical research dermatologics, drug safety and pharmacovigilance, surfactant science and skin care, regulatory submissions and regulatory affairs, leader in cosmetic field and past (elected) president of Society of Cosmetic Chemists, 50+ publications and editor of 3 books, past adjunct professor Fairleigh Dickinson Masters Program in Cosmetic Science